Vitamin D in Ventilated ICU Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Respiratory Failure
Interventions
DRUG

Enteral Vitamin D3 50,000 IU

Enteral Vitamin D3 50,000IU x 5 days (total dose 250,000IU)

DRUG

Enteral Vitamin D3 100,000IU

Enteral Vitamin D3 100,000IU over 5 days (total 500,000IU)

OTHER

Inactive substance

Inactive substance given enterally for 5 days.

Trial Locations (2)

30308

Emory University Hospital Midtown, Atlanta

30322

Emory University Hospital, Atlanta

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Emory University

OTHER

NCT01372995 - Vitamin D in Ventilated ICU Patients | Biotech Hunter | Biotech Hunter